BNP Paribas’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.16M Sell
2,457
-12
-0.5% -$6.04K 0.04% 169
2025
Q4
$1.15M Buy
2,469
+126
+5% +$58.5K 0.03% 174
2025
Q3
$999K Sell
2,343
-44
-2% -$17.1K 0.03% 163
2025
Q2
$914K Sell
2,387
-251
-10% -$90.4K 0.03% 174
2025
Q1
$912K Sell
2,638
-237
-8% -$76.2K 0.04% 176
2024
Q4
$863K Buy
2,875
+105
+4% +$36.7K 0.01% 185
2024
Q3
$1.13M Buy
2,770
+456
+20% +$167K 0.05% 149
2024
Q2
$743K Buy
2,314
+1,345
+139% +$437K 0.04% 173
2024
Q1
$323K Buy
+969
New +$296K 0.02% 220

Other funds holding HCA

BNP Paribas's HCA Position: Q1 2026 in Review

BNP Paribas reduced its HCA Healthcare (HCA) stake by 0.49% in Q1 2026, selling an estimated $6.04K and leaving 2,457 shares worth $1.16M. The position accounts for 0.04% of the portfolio, ranked #169.

BNP Paribas first reported a position in HCA in Q1 2024 and has held it in 9 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • BNP Paribas held 2,457 shares of HCA Healthcare worth $1.16M as of Q1 2026.
  • BNP Paribas sold 12 HCA Healthcare shares in Q1 2026, an estimated $6.04K.
  • HCA Healthcare made up 0.04% of BNP Paribas's portfolio in Q1 2026, its #169 holding.
  • BNP Paribas first reported a position in HCA Healthcare in Q1 2024 and has held it in 9 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.